Cynata Therapeutics: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 24 pages · English
The Annual General Meeting of the Company will be held at the Board Room, Level 2, 62 Lygon Street, Carlton South, Victoria 3053, on 17 November 2017 at 9.30 am (AEDT) This Notice of Annual General Meeting should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their accountant, solicitor or other professional adviser prior to voting. S
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Cynata to Increase Exposure in Japan
- US Patent Granted for Cynata Cymerus Technology
- Health Canada Meeting Advances CYP Global Development Plans
- Positive Data from CYP MSCs in 2nd Preclinical Asthma Study
- June 2017 Quarterly Report
Later from Cynata Therapeutics
- September 2017 Quarterly Report
- Enrolment Completed in 1st Cohort of Cynata Clinical Trial
- United States Patent Allowance for Core Cynata Technology
- Final Preclinical Asthma Study Confirms Efficacy
- Encouraging Early Data-Cynata Clinical Trial Proceeds
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics